China Health Industries Holdings, Inc.
CHHE · OTC
3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $38 | $58 |
| % Growth | 89.1% | -99.9% | -33.4% | – |
| Cost of Goods Sold | $0 | $83 | $38 | $63 |
| Gross Profit | -$70 | -$83 | -$95 | -$5 |
| % Margin | -80,106.9% | -180,308.7% | -246.8% | -8.9% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $73 | $363 | $89 | $574 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $70 | $0 | $95 | -$8 |
| Operating Expenses | $142 | $363 | $184 | $604 |
| Operating Income | -$142 | -$446 | -$184 | -$610 |
| % Margin | -163,512.6% | -968,597.8% | -480.3% | -1,059.9% |
| Other Income/Exp. Net | -$0 | $0 | $2 | $18 |
| Pre-Tax Income | -$143 | -$446 | -$182 | -$591 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$143 | -$446 | -$182 | -$591 |
| % Margin | -164,082.8% | -968,602.2% | -476.1% | -1,028.2% |
| EPS | -0.002 | -0.007 | -0.003 | -0.009 |
| % Growth | 67.6% | -142.9% | 68.9% | – |
| EPS Diluted | -0.002 | -0.007 | -0.003 | -0.009 |
| Weighted Avg Shares Out | 65,543 | 65,540 | 65,540 | 65,540 |
| Weighted Avg Shares Out Dil | 65,540 | 65,540 | 65,540 | 65,540 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $2 | $26 |
| Interest Expense | $1 | $1 | $0 | $0 |
| Depreciation & Amortization | $70 | $83 | $95 | $159 |
| EBITDA | -$73 | -$363 | -$88 | -$1,866 |
| % Margin | -83,405.7% | -788,289.1% | -229.3% | -3,244.3% |